chromic phosphate has been researched along with phosphorus radioisotopes in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 48 (60.00) | 18.7374 |
1990's | 21 (26.25) | 18.2507 |
2000's | 5 (6.25) | 29.6817 |
2010's | 6 (7.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carnes, H; Galeazzi, H; Ramel, P; Rösler, H | 1 |
Fig, LM; Shapiro, B; Taren, J | 1 |
Cain, JM; Lee, RB; Peters, WA; Smith, MR; Yon, JL | 1 |
Berchuck, A; Clarke-Pearson, DL; Soper, JT | 1 |
Rubinstein, L; Walton, LA; Yadusky, A | 1 |
McDermott, RL; Sprengelmeyer, JT | 1 |
Anghileri, LJ; Maincent, P; Marchal, C; Robert, J | 1 |
Austin, JM; Hatch, KD; Kim, RY; Partridge, EE; Potter, ME; Shingleton, HM; Soong, SJ | 1 |
Boyes, D; Carmichael, J; Fraser, R; Gerulath, A; Kirk, M; Klaassen, D; Levitt, M; Methot, Y; Shelley, W; Starreveld, A | 1 |
Bakshi, S; Emrich, LJ; Lele, SB; Parthasarathy, KL; Piver, MS | 1 |
Heath, R; Rosenman, J; Varia, M; Walton, L | 1 |
Askin, F; Currie, J; Fowler, W; Halle, J; Rosenman, J; Varia, M; Venkatraman, S; Walton, L | 1 |
Howson, MP; Mitchell, NS; Shepard, NL | 1 |
Burrell, MO; Kirchner, AB; Powell, JL | 1 |
Bandy, LC; Clarke-Pearson, DL; Creasman, WT; Soper, JT; Wilkinson, RH | 1 |
Ehrlich, CE; Hornback, NB; Reddy, S; Stehman, FB; Sutton, GP | 1 |
Flower, MA; Jones, A; McCready, VR; Ott, RJ | 1 |
Gumerman, L; Levine, G; Lunsford, LD | 1 |
Clarke-Pearson, DL; Creasman, WT; Johnston, WW; Soper, JT; Sullivan, DC; Vergadoro, F | 1 |
Boyes, D; Gerulath, A; Klaassen, D; Levitt, M; Miller, A; Shelly, W; Starreveld, A | 1 |
Bélanger, RD; Danais, S; Girard, M; Guay, JP; Jutras, M; Lamarre, C; Rivard, GE | 1 |
Major, W; Neutze, J; Van Nostrand, D | 1 |
Kageyama, N; Kobayashi, T; Ohara, K | 1 |
Bakri, YN; Given, FT | 1 |
Carlson, JA; Jose, B; Osborne, RP; Sharma, SC | 2 |
Kirchner, AB; Powell, JL | 1 |
Cubberley, D; Datz, FL; Taylor, A | 1 |
Adelstein, SJ; Bloomer, WD; Gordon, PR; McLaughlin, WH; Neirinckx, RD; Ruth, TJ; Wolf, AP | 1 |
Backx, C; Cash, SA; Durand, RE; Leichner, PK | 1 |
Bagne, F; Creasman, WT; Currie, JL; Harris, C; Sullivan, DL; Surwit, EA; Wilkinson, RH | 1 |
Blosser, NM; Jackson, GL | 1 |
Blessing, J; Creasman, WT; Disaia, PJ; Johnston, W; Weed, JC; Wilkinson, RH | 1 |
Cabrini, RL; Silberman, FS; Ubios, AM | 1 |
Abdel-Dayem, H; Collier, BD; Hamilton, K; Ozker, K; Pattillo, RA; Ruckert, AC; Wilson, C | 1 |
Hung, JC | 1 |
McGowan, L | 1 |
Siegel, JA | 1 |
Eggli, DF; Tulchinsky, M | 1 |
Bélanger, R; Girard, M; Guay, JP; Jutras, M; Marton, D; Rivard, GE | 1 |
DeVictoria, CL; Gaudette, DE; Goldberg, GL; Milstein, DM; Runowicz, CD; Smith, HO | 1 |
Anderson, E; Luck, JV; Quines, C; Siegel, HJ; Siegel, ME | 1 |
Wilkinson, RH | 1 |
Khan, SH; Siegel, JA | 1 |
Day, TG; Doering, D; Makhija, S; Spanos, WJ | 1 |
Boccio, JR; Caro, RA; Lanari, E; Nicolini, JO; Ughetti, R; Zubillaga, MB | 1 |
Corn, B; Lanciano, R; Randall, M; Reddy, S | 1 |
Dempke, W; Firusian, N | 1 |
Bush, CH; Drane, WE | 1 |
Luck, JV; Siegel, ME; Silva, M | 1 |
Alvarez, RD; Benda, JA; Bundy, BN; Clarke-Pearson, DL; Long, HJ; Stehman, FB; Varia, MA | 1 |
MUMMA, CS | 1 |
JAFFE, HL; RUSCHE, C | 2 |
CUTLER, JL; GABRIELI, ER; GOULIAN, D | 1 |
BLUM, E; BURG, C; CHEVALLIER, A; FRUHLING, L | 1 |
GAMBLE, D; LIBBY, RL; MOORE, V | 1 |
LANGE, RH; ROZENDAAL, HM; SHIELDS, JL | 1 |
BULKLEY, GJ; COOPER, JA; O'CONOR, VJ | 1 |
CANOY, NR | 1 |
JACOBS, ML | 1 |
PERL, JI; WHITLOCK, DG | 1 |
JOHNSON, PC; RUTLEDGE, BJ; WEST, KM | 1 |
LAUSTELA, E; SCHEININ, TM | 2 |
BECKER, G; PIPPIG, L; SCHMITT, W | 1 |
CLARKE, KH; HOLMAN, WP; VAN DEN BRENK, HA; WINKLER, C | 1 |
BLUM, E; BURG, C; CHEVALLIER, A | 1 |
HILL, JM; LAJOUS, JR; MARSHALL, GJ; SPEER, RJ | 1 |
Alberts, DS; Brady, MF; Hurteau, J; Lentz, SS; Long, HJ; Mayer, AR; Nieberg, RK; Young, RC | 1 |
BURSTONE, MS | 1 |
GOVAERTS, J; HERVE, A | 2 |
Casale, G; Durán, H; Nicolini, J; Palmieri, M; Papparella, ML; Pirchio, R; Salgueiro, MJ; Ughetti, R; Zubillaga, M | 1 |
Adler, Z; Bush, CH; Drane, WE; Gibbs, CP; Scarborough, MT; Tamurian, R | 1 |
Gao, W; Jiang, B; Liu, L; Liu, XN; Liu, ZY; Wang, Y | 1 |
Chen, D; Gao, H; Huang, P; Liu, L; Nie, Q; Qi, B; Wu, Q; Yang, Z | 1 |
He, X; Huang, P; Jia, R; Li, W; Liang, K; Shao, G; Wang, Z; Xu, L | 1 |
Chen, S; Mo, J; Wu, S; Xiong, G | 1 |
Huang, P; Liu, X; Shao, G; Song, J; Wang, F; Wang, Y; Wang, Z; Zhao, M | 1 |
2 review(s) available for chromic phosphate and phosphorus radioisotopes
Article | Year |
---|---|
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy | 1991 |
Update on the role of radiotherapy in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromium Compounds; Combined Modality Therapy; Female; Humans; Injections, Intraperitoneal; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Phosphates; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Salvage Therapy; Technetium Tc 99m Sulfur Colloid | 1998 |
9 trial(s) available for chromic phosphate and phosphorus radioisotopes
Article | Year |
---|---|
Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
Topics: Adult; Aged; Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Intestines; Life Tables; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Reoperation; Survival Analysis | 1992 |
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy | 1991 |
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.
Topics: Chromium; Chromium Compounds; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Random Allocation | 1988 |
External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report.
Topics: Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes | 1985 |
Intraperitoneal distribution imaging prior to chromic phosphate (P-32) therapy in ovarian cancer patients.
Topics: Chromium Compounds; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radionuclide Imaging; Sodium Chloride; Technetium Tc 99m Sulfur Colloid; Tissue Distribution | 1994 |
Body contour determination and validation for bremsstrahlung SPECT imaging.
Topics: Chromium Compounds; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Pancreatic Neoplasms; Phantoms, Imaging; Phosphates; Phosphorus Radioisotopes; Scattering, Radiation; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chromium Compounds; Digestive System Neoplasms; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphates; Phosphorus Radioisotopes; Survival Rate | 1999 |
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome | 2003 |
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Chromium Compounds; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Survival Rate; Treatment Outcome | 2003 |
70 other study(ies) available for chromic phosphate and phosphorus radioisotopes
Article | Year |
---|---|
[Synoviorthesis of the knee joint with 32P-chromic phosphate (author's transl)].
Topics: Chromium; Chromium Compounds; Colloids; Humans; Middle Aged; Phosphates; Phosphorus Radioisotopes; Synovitis | 1979 |
Distribution of [32P]-chromic phosphate colloid in cystic brain tumors.
Topics: Brain Neoplasms; Chromium; Chromium Compounds; Colloids; Cysts; Glioma; Humans; Phosphates; Phosphorus Radioisotopes; Radiosurgery; Stereotaxic Techniques | 1992 |
Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Topics: Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Retrospective Studies; Survival Analysis | 1991 |
Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion.
Topics: Aged; Chromium; Chromium Compounds; Colloids; Humans; Male; Pericardial Effusion; Phosphates; Phosphorus Radioisotopes; Primary Myelofibrosis | 1990 |
Improvement of radioactive colloid binding by tumor cells.
Topics: Adsorption; Animals; Chromium; Chromium Compounds; Colloids; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred Strains; Phosphates; Phosphorus Radioisotopes; Polylysine | 1990 |
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
Topics: Chromium; Chromium Compounds; Female; Humans; Instillation, Drug; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes | 1989 |
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Time Factors | 1988 |
Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy.
Topics: Ascitic Fluid; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Hysterectomy; Injections, Intraperitoneal; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms | 1988 |
Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
Topics: Carcinoma; Chromium; Chromium Compounds; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Reoperation | 1988 |
Colloidal chromic phosphate 32P synovectomy in antigen-induced arthritis in the rabbit.
Topics: Animals; Arthritis; Arthritis, Experimental; Autoradiography; Cartilage, Articular; Chromium; Chromium Compounds; Colloids; Evaluation Studies as Topic; Knee Joint; Methods; Phosphates; Phosphorus Radioisotopes; Rabbits; Radiation Injuries, Experimental; Synovial Membrane; Time Factors | 1988 |
Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Topics: Adenocarcinoma; Brachytherapy; Chromium; Chromium Compounds; Cystadenocarcinoma; Endometriosis; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes | 1987 |
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Papillary; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Reoperation | 1987 |
Ovarian carcinoma: adjuvant treatment with P-32.
Topics: Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Posture; Radiotherapy Dosage | 1987 |
The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT.
Topics: Chromium; Chromium Compounds; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Phosphates; Phosphorus Radioisotopes; Radiation Dosage; Tomography, Emission-Computed | 1985 |
Stereotactic intracavitary irradiation of cystic neoplasms of the brain.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Cerebral Ventricle Neoplasms; Child; Child, Preschool; Chromium; Chromium Compounds; Colloids; Craniopharyngioma; Cysts; Female; Humans; Male; Middle Aged; Phosphates; Phosphorus Radioisotopes; Pituitary Neoplasms; Stereotaxic Techniques | 1985 |
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
Topics: Adenocarcinoma; Brachytherapy; Catheters, Indwelling; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Hysterectomy; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms | 1985 |
Synoviorthesis with colloidal 32P chromic phosphate for hemophilic arthropathy: clinical follow-up.
Topics: Adolescent; Adult; Child; Chromium; Chromium Compounds; Colloids; Elbow Joint; Follow-Up Studies; Hemarthrosis; Hemophilia A; Humans; Injections, Intra-Articular; Knee Joint; Phosphates; Phosphorus Radioisotopes; Radiation Monitoring; Synovitis | 1985 |
Peritoneoscintigraphy in detection of improper placement of peritoneal catheter into bowel lumen prior to chromic phosphate P-32 therapy. A case report.
Topics: Adenocarcinoma; Brachytherapy; Catheterization; Chromium; Chromium Compounds; Colonic Neoplasms; Female; Humans; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid | 1985 |
Internal irradiation for cystic craniopharyngioma.
Topics: Adolescent; Adult; Child, Preschool; Chromium; Chromium Compounds; Craniopharyngioma; Female; Follow-Up Studies; Gold Colloid, Radioactive; Humans; Male; Methods; Middle Aged; Phosphates; Phosphorus Radioisotopes; Pituitary Neoplasms; Radiotherapy Dosage; Tomography, X-Ray Computed | 1981 |
Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites.
Topics: Adult; Aged; Ascites; Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Kinetics; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Uterine Neoplasms | 1984 |
Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
Topics: Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiation Dosage | 1984 |
Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
Topics: Adult; Breast Feeding; Chromium; Chromium Compounds; Cystadenocarcinoma; Female; Humans; Infant, Newborn; Injections, Intraperitoneal; Milk, Human; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Pregnancy; Pregnancy Complications, Neoplastic | 1983 |
Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis | 1984 |
Value of preinjection tracer before P-32 treatment of effusion: unexpected bronchopleural fistula.
Topics: Bronchial Fistula; Chromium; Chromium Compounds; Fistula; Humans; Male; Middle Aged; Phosphates; Phosphorus Radioisotopes; Pleural Diseases; Pleural Effusion; Radionuclide Imaging; Sulfur; Technetium; Technetium Tc 99m Sulfur Colloid | 1982 |
Astatine-211--tellurium radiocolloid cures experimental malignant ascites.
Topics: Alpha Particles; Animals; Ascites; Astatine; Cell Survival; Chromium; Chromium Compounds; Colloids; Female; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radioisotopes; Tellurium; Transplantation, Homologous | 1981 |
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
Topics: Animals; Autoradiography; Carcinoma; Cell Line; Chromium; Chromium Compounds; Cricetinae; Diaphragm; Dose-Response Relationship, Radiation; Female; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Rats | 1981 |
Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients.
Topics: Absorption; Animals; Autoradiography; Chromium; Chromium Compounds; Dogs; Female; Humans; Infusions, Parenteral; Kinetics; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiometry; Suspensions; Thermoluminescent Dosimetry; Tissue Distribution | 1981 |
Intracavitary chromic phosphate (32P) colloidal suspension therapy.
Topics: Brachytherapy; Chromium; Chromium Compounds; Follow-Up Studies; Humans; Male; Neoplasms; Peritoneal Diseases; Peritoneum; Phosphates; Phosphorus Radioisotopes; Pleura; Pleural Effusion | 1981 |
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Topics: Adenocarcinoma; Ascitic Fluid; Chromium; Chromium Compounds; Female; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1981 |
Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy.
Topics: Carcinogens; Chromium Compounds; Colloids; Humans; Injections, Intra-Articular; Phosphates; Phosphorus Radioisotopes | 1995 |
Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Topics: Adenocarcinoma; Cell Survival; Chromium Compounds; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Survival Rate; Tumor Cells, Cultured | 1995 |
Unit dose dispensing of chromic phosphate P 32 suspension.
Topics: Chromium Compounds; Drug Labeling; Humans; Medication Errors; Phosphates; Phosphorus Radioisotopes; Suspensions | 1994 |
Adjuvant intraperitoneal chromic phosphate therapy in a woman with early ovarian carcinoma and pelvic infection with resulting catastrophic complications.
Topics: Adult; Chromium Compounds; Contraindications; Cystadenoma, Mucinous; Female; Humans; Hysterectomy; Instillation, Drug; Ovarian Neoplasms; Pelvic Inflammatory Disease; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Radiotherapy, Adjuvant | 1994 |
Quantitative bremsstrahlung SPECT imaging: attenuation-corrected activity determination.
Topics: Chromium Compounds; Humans; Models, Structural; Neoplasms; Phosphates; Phosphorus Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy.
Topics: Adolescent; Adult; Child; Chromium Compounds; Chromosomes, Human; Colloids; Hemarthrosis; Humans; Injections, Intra-Articular; Joints; Male; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Range of Motion, Articular; Synovial Membrane | 1994 |
Single-use percutaneous catheters for intraperitoneal P32 therapy.
Topics: Adult; Aged; Catheterization; Catheterization, Central Venous; Chromium Compounds; Disposable Equipment; Endometrial Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Retrospective Studies | 1994 |
Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment.
Topics: Adolescent; Adult; Child; Chromium Compounds; Colloids; Follow-Up Studies; Hemarthrosis; Hemophilia A; Humans; Injections, Intra-Articular; Middle Aged; Phosphates; Phosphorus Radioisotopes; Recurrence; Synovial Membrane; Synovitis | 1994 |
Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
Topics: Chromium Compounds; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Pleura; Pleural Effusion; Technetium Tc 99m Sulfur Colloid; Time Factors; Tissue Distribution | 1996 |
CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients.
Topics: CA-125 Antigen; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Postoperative Period; Reoperation; Retrospective Studies | 1996 |
Use of colloids of chromic [32P] phosphate in treatment of solid tumors.
Topics: Adenocarcinoma; Animals; Chromium Compounds; Colloids; Female; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Phosphates; Phosphorus Radioisotopes; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1996 |
Treatment of an aneurysmal bone cyst of the spine by radionuclide ablation.
Topics: Adolescent; Bone Cysts, Aneurysmal; Chromium Compounds; Female; Humans; Injections; Magnetic Resonance Imaging; Phosphates; Phosphorus Radioisotopes; Radiopharmaceuticals; Spinal Diseases; Tomography, X-Ray Computed | 2000 |
32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Chromium Compounds; Chronic Disease; Combined Modality Therapy; Follow-Up Studies; Hemarthrosis; Hemophilia A; Hemorrhage; Humans; Injections, Intra-Articular; Middle Aged; Phosphates; Phosphorus Radioisotopes; Retrospective Studies; Risk Assessment; Synovectomy; Synovitis; Treatment Outcome | 2001 |
Treatment of mixed tumor of tongue with radioactive chromic phosphate solution.
Topics: Chromium Compounds; Humans; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Tongue; Tongue Neoplasms | 1953 |
The treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (P32); preliminary report.
Topics: Chromium Compounds; Humans; Male; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Prostatic Neoplasms | 1953 |
Treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (p32); a preliminary report.
Topics: Chromium Compounds; Humans; Male; Phosphates; Phosphorus; Phosphorus Radioisotopes; Prostatic Neoplasms | 1954 |
Hepatic radioautography following intravenous injection of radioactive chromium phosphate as a further contribution to reticulo-endothelial functional tests.
Topics: Autoradiography; Chromium Compounds; Humans; Injections, Intravenous; Liver; Mononuclear Phagocyte System; Phosphates; Phosphorus; Phosphorus Radioisotopes; Radiography | 1955 |
[Histological data on a bladder epithelioma treated by radiophosphorus-labeled colloidal chromic phosphate].
Topics: Chromium; Chromium Compounds; Humans; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Urinary Bladder Neoplasms | 1955 |
Experiences with radioactive chromic phosphate in urological tumors.
Topics: Chromium; Chromium Compounds; Humans; Phosphates; Phosphorus; Phosphorus Radioisotopes; Urinary Bladder Neoplasms; Urologic Neoplasms | 1956 |
Colloidal radioactive chromic phosphate in the control of malignant effusions.
Topics: Chromium Compounds; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Pleural Effusion, Malignant | 1956 |
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
Topics: Carcinoma; Chromium Compounds; Gold Radioisotopes; Humans; Male; Phosphates; Phosphorus; Phosphorus Radioisotopes; Prostatic Neoplasms; Yttrium | 1957 |
Radio-active colloidal chromic phosphate in the treatment of carcinoma of the urinary bladder.
Topics: Chromium; Chromium Compounds; Humans; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Urinary Bladder Neoplasms | 1957 |
Radioactive colloidal chromic phosphate to control pleural effusion and ascites.
Topics: Ascites; Chromium Compounds; Exudates and Transudates; Humans; Phosphates; Phosphorus; Phosphorus Radioisotopes; Pleural Effusion; Pleurisy | 1958 |
Use of radioactive colloidal chromic phosphate for prevention of amputation neuroma.
Topics: Amputation, Surgical; Chromium Compounds; Humans; Neuroma; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary | 1958 |
Destruction of the hypophysis with radioactive colloidal chromic phosphate in cancer of the prostate.
Topics: Chromium Compounds; Humans; Male; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Pituitary Gland; Prostatic Neoplasms | 1958 |
Distribution of colloidal radioactive chromic phosphate (CRP32O4) after intrapleural injection in the guinea pig.
Topics: Chromium Compounds; Guinea Pigs; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Pleura; Radioactivity | 1958 |
Comparative study of the distribution of intrapleurally injected colloidal radioactive chromic phosphate (CrP32O4) and gold (Au198) in the guinea pig.
Topics: Chromium Compounds; Gold; Gold Radioisotopes; Guinea Pigs; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Pleura; Radioactivity | 1958 |
[Quantitative determination of the liver blood supply with use of a colloidal radioactive chromium phosphate].
Topics: Chromium Compounds; Liver; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Radioactivity | 1961 |
Studies of the effect of a colloidal radioactive chromic phosphate (Cr32PO4) in clincal and experimental malignant effusions.
Topics: Chromium; Chromium Compounds; Chromium Radioisotopes; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Pleural Effusion, Malignant | 1959 |
[Treatment of malignant tumors of the bladder with radiophosphorus-labeled colloidal chromic phosphate].
Topics: Chromium; Chromium Compounds; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Urinary Bladder Neoplasms | 1955 |
Colloidalradioisotope therapy in leukemia with special reference to chromic phosphate P-32.
Topics: Chromium Compounds; Humans; Leukemia; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary | 1955 |
Studies on the alterations of development of the teeth and adjacent structures following local administration of chromic phosphate containing P32.
Topics: Chromium Compounds; Humans; Phosphates; Phosphorus; Phosphorus Radioisotopes; Radiopharmaceuticals; Tooth | 1951 |
[Study of the distribution in the organs of intravenous injections of radioactive chromium phosphate].
Topics: Anesthesia; Anesthesiology; Chromium Compounds; Humans; Injections, Intravenous; Phosphates; Phosphorus Radioisotopes | 1951 |
[Elimination of radiophosphorus in certain neoplastic diseases; first experiences with radioactive colloidal chromium phosphate].
Topics: Chromium Compounds; Neoplasms; Phosphates; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary | 1952 |
Design and bioevaluation of a 32P-patch for brachytherapy of skin diseases.
Topics: Animals; Brachytherapy; Chromium Compounds; Drug Delivery Systems; Female; Histocytochemistry; Mice; Mice, Inbred SENCAR; Phosphates; Phosphoric Acids; Phosphorus Radioisotopes; Radiotherapy Planning, Computer-Assisted; Random Allocation; Rubber; Silicones; Skin Neoplasms | 2008 |
Percutaneous radionuclide ablation of axial aneurysmal bone cysts.
Topics: Adolescent; Bone Cysts, Aneurysmal; Child; Chromium Compounds; Female; Humans; Injections, Intralesional; Male; Phosphates; Phosphorus Radioisotopes; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma.
Topics: Animals; Chromium Compounds; Humans; Injections, Intralesional; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphates; Phosphorus Radioisotopes; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Safety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.
Topics: Animals; Chromium Compounds; Dogs; Drug Implants; Female; Half-Life; Lactic Acid; Liver; Male; Phosphates; Phosphorus Radioisotopes; Polyesters; Polymers; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2012 |
³²P-chromic phosphate-Poly(L-Lactide) seeds of sustained release and their brachytherapy for prostate cancer with lymphatic metastasis.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Chromium Compounds; Humans; Lactic Acid; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Phosphates; Phosphorus Radioisotopes; Polyesters; Polymers; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Topics: Apoptosis; Blotting, Western; Cell Proliferation; Chromium Compounds; Colony-Forming Units Assay; DNA-(Apurinic or Apyrimidinic Site) Lyase; Flow Cytometry; Humans; In Vitro Techniques; Pancreatic Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiation Tolerance; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
Investigation of Newly Prepared Biodegradable
Topics: Animals; Brachytherapy; Chromium Compounds; Glioma; Half-Life; Heterografts; Humans; Mice; Microscopy, Electron, Scanning; Phosphates; Phosphorus Radioisotopes; Polylactic Acid-Polyglycolic Acid Copolymer; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2018 |